Overview

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects with Opioid-Induced Constipation

Phase:

Phase 2

Details

Lead Sponsor:

Theravance Biopharma
Theravance Biopharma R & D, Inc.

Treatments:

Analgesics, Opioid